TrialAdvances in rheumatology (London, England)2023
Efficacy and safety of different Janus kinase inhibitors combined with methotrexate for the treatment of rheumatoid arthritis: a single-center randomized trial.
Xiaoling Liao et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papertrialcites it